by Physicians Weekly | Apr 3, 2012 | Articles, News Brief, Oncology
The FDA has approved a supplemental new drug application for a subcutaneous form of bortezomib (Velcade, Millennium). The drug is indicated for the adjuvant treatment of multiple myeloma and mantle cell lymphoma. Source:...
